LabGenomics co. Ltd. is a company specialized in molecular diagnostics healthcare, and has grown with molecular diagnostic market through development of effective diagnosis and new diagnosis methods. On that basis, establishing a bridgehead for local and overseas business, we are expanding our area to the diverse diagnostic services such as NGS-NIPT test and Cancer panel by recently combining NGS(Nest Generation Sequencing) technology and BI(Bioinformatics) analysis with diagnostics industry which is our main business. With base of our own technology, know-how, and clinical data, LabGenomics will make every effort to provide people with high quality healthcare benefits by realizing early diagnosis, preventive medicine, and personalized medicine. Creating synergy with our core competencies and business strategy, we do our best to become a ‘Global company specialized in molecular diagnostics healthcare‘
moreEXHIBIT
Geno PAC Cancer/Disease
Personal genome service for prediction of cancer and chronic diseases Based on SNP Prediction of Man 11, Woman 12 kinds of cancer including nationally designated 5 kinds of cancer (stomach, large?intestine, liver, breast, ovary) Prediction of 15 kinds of chronic disease including Alzheimers, Parkinson’s disease, and Myocardial infarction Provision healthcare guide for precaution
More
COMPANY INTRODUCTION
LabGenomics co. Ltd. is a company specialized in molecular diagnostics healthcare, and has grown with molecular diagnostic market through development of effective diagnosis and new diagnosis methods. On that basis, establishing a bridgehead for local and overseas business, we are expanding our area to the diverse diagnostic services such as NGS-NIPT test and Cancer panel by recently combining NGS(Nest Generation Sequencing) technology and BI(Bioinformatics) analysis with diagnostics industry which is our main business. With base of our own technology, know-how, and clinical data, LabGenomics will make every effort to provide people with high quality healthcare benefits by realizing early diagnosis, preventive medicine, and personalized medicine. Creating synergy with our core competencies and business strategy, we do our best to become a ‘Global company specialized in molecular diagnostics healthcare‘
